EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder

Clinical Neurophysiology

Volumn 121, Issue 9, 2010, Pages 1511-1518

  Sander, Christian ^a   Arns, Martijn ^b,c   Olbrich, Sebastian ^a   Hegerl, Ulrich ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b RESEARCH INSTITUTE BRAINCLINICS   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

ADHD; CPT; EEG; Response prediction; Stimulants

Indexed keywords

ATOMOXETINE; DEXAMPHETAMINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ALERTNESS; ALGORITHM; ALPHA RHYTHM; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; ELECTROENCEPHALOGRAM; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; STIMULUS RESPONSE; THETA RHYTHM; TREATMENT OUTCOME;

EID: 77955270380     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.03.021     Document Type: Article

References (67)

1. Arns M., de Ridder S., Strehl U., Breteler M., Coenen A. Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci 2009, 40(3):180-189.
2. Arns M., Gunkelmann J., Breteler M., Spronk D. EEG Phenotypes predict treatment outcome to stimulants in children with ADHD. J Integr Neurosci 2008, 7(3):1-18.
3. Barry R.J., Clarke A.R., Johnstone S.J. A review of electrophysiology in attention-deficit/hyperactivity disorder: I qualitative and quantitative electroencephalography. Clin Neurophysiol 2003, 114:171-183.
4. Benner-Davis S., Heaton P.C. Attention deficit and hyperactivity disorder: controversies of diagnosis and safety of pharmacological and non-pharmacological treatment. Curr Drug Saf 2007, 2(1):33-42.
5. Bente D. Die Insuffizienz des Vigilitätstonus. Habilitation, University of Erlangen, 1964.
6. Bresnahan S.M., Anderson J.W., Barry R.J. Age-related changes in quantitative EEG in attention deficit hyperactivity disorder. Biol Psychiatry 1999, 46:1690-1697.
7. Bresnahan S.M., Barry R.J. Specificity of quantitative EEG analysis in adults attention deficit hyperactivity disorder. Psychiatry Res 2002, 112:133-144.
8. Bukstein O. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 2008;19(2):242-253, viii.
9. Cantero J.L., Atienza M., Salas R.M. Human alpha oscillations in wakefulness, drowsiness period, and REM sleep: different electroencephalographic phenomena within the alpha band. Neurophysiol Clin 2002, 32:54-71.
10. Castellanos F.X., Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Neuroscience 2002, 3:617-628.
11. Chabot R.J., Orgill A.A., Crawford G., Harris M.J., Serfontein G. Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. J Child Neurol 1999, 14(6):343-351.
12. Chabot R.J., Serfontein G. Quantitative electroencephalographic profiles of children with attention deficit disorder. Biol Psychiatry 1996, 40(10):951-963.
13. Clark C.R., Paul R.H., Williams L.M., Arns M., Fallahpour K., Handmer C., et al. Standardized assessment of cognitive functioning during development and ageing using an automated touchscreen battery. Arch Clin Neuropsychol 2006, 21:449-467.
14. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M. EEG analysis in attention-deficit/hyperactivity disorder: a comparative study of two subtypes. Psychiatry Res 1998, 81:19-29.
15. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M. Excess beta in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Res 2001, 103:205-218.
16. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M. EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Psychophysiology 2001a. Clin Neurophysiol 2001, 112:2098-2105.
17. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2002, 113(2):194-205.
18. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M., Brown C.R. EEG evidence for a new conceptualisation of attention deficit hyperactivity disorder. Clin Neurophysiol 2002, 113(7):1036-1044.
19. Clarke A.R., Barry R.J., Bond D., McCarthy R., Selikowitz M. Effects of stimulant medications on the EEG of children with attention-deficit/hyperactivity disorder. Psychopharmacology 2002, 164:277-284.
20. Clarke A.R., Barry R.J., McCarthy R., Selikowith M., Brown C.R., et al. Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type. Int J Psychophysiol 2003, 47(2):129-137.
21. Clarke A.R., Barry R.J., McCarthy R., Selikowitz M., Johnstone S.J. Effects of stimulant medications on the EEG of girls with attention-deficit/hyperactivity disorder. Clin Neurophysiol 2007, 118(12):2700-2708.
22. Cormier E. Attention deficit/hyperactivity disorder: a review and update. J Pediatr Nurs 2008, 23(5):345-357.
23. Davidson M.A. ADHD in adults: a review of the literature. J Atten Disord 2008, 11(6):628-641.
24. Daviss W.B. A review of co-morbid depression in pediatric ADHD: etiology, phenomenology, and treatment. J Child Adolesc Psychopharmacol 2008, 18(6):565-571.
25. De Gennaro L., Ferrara M., Curcio G., Cristiani R. Antero-posterior EEG changes during the wakefulness-sleep transition. Clin Neurophysiol 2001, 112:1901-1911.
26. di Michele F., Pricep L., John E.R., Chabot R.J. The neurophysiology of attention-deficit/hyperacitivity disorder. Int J Psychophysiol 2005, 58:81-93.
27. Ghuman J.K., Arnold L.E., Anthony B.J. Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol 2008, 18(5):413-447.
28. Gordon E. Integrative neuroscience in psychiatry: the role of a standardized database. Australas Psychiatry 2003, 11:156-163.
29. Gordon E., Cooper N., Rennie C., Hermens D., Williams L. Integrative neuroscience. The role of a standardized database. Clin EEG Neurosci 2005, 36:53-75.
30. Gratton G., Coles M.G., Doncin E. A new method for off-line removal of acular artefact. Electroencephalogr Clin Neurophysiol 1983, 55:468-484.
31. Greenhill L.L., Halperin J.M., Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry 1999, 38(5):503-512.
32. Hegerl U., Himmerich H., Engmann B., Hensch T. Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment?. Curr Opin Psychiatry 2010, 23:1-7.
33. Hegerl U., Olbrich S., Schönknecht P., Sander C. Manic behaviour as an autoregulatory attempt to stabilize vigilance. Nervenarzt 2008, 79(11):1283-1290.
34. Hegerl U., Stein M., Mulert C., Mergl R., Olbrich S., Dichgans E., et al. EEG-vigilance differences between patients with borderline personality disorder, patients with obsessive-compulsive disorder and healthy controls. Eur Arch Psychiatry Clin Neurosci 2008, 258:137-143.
35. Hegerl U., Sander C., Olbrich S., Schönknecht P. Are psychostimulants a treatment option in mania?. Pharmacopsychiatry 2009, 42(5):169-174.
36. Hermens D.F., Williams L.M., Clarke S., Kohn M., Cooper N., Gordon E. Responses to methylphenidate in adolescent AD/HD: Evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int J Psychophysiol 2005, 58(1):21-33.
37. Hermens D.F., Cooper N.J., Kohn M., Clarke S., Gordon E. Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J Integr Neurosci 2005, 4(1):107-121.
38. Hervey A.S., Epstein J.N., Curry J.F., Tonev S., Arnold L.E., Conners C.K., et al. Reaction time distribution analysis of neuropsychological performance in an ADHD sample. Child Neurophysiol 2006, 12(2):125-140.
39. Kavale K. The efficacy of stimulant drug treatment for hyperactivity: a meta-analysis. J Learn Disabil 1982, 15:280-289.
40. Kaida K., Takahashi M., Akerstedt T., Nakata A., Otsuka Y., Haratani T., et al. Validation of the Karolinska sleepiness scale against performance and EEG variables. Clin Neurophysiol 2006, 117:1574-1581.
41. Knight L.A., Rooney M., Chronis-Tuscano A. Psychosocial treatments for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2008, 10(5):412-418.
42. Lazzaro I., Gordon E., Whitmont S., Plahn M., Li W., Clarke S., et al. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin Electroencephalogr 1998, 29(1):37-42.
43. Lerner M., Wigal T. Long-term safety of stimulant medications used to treat children with ADHD. J Psychosoc Nurs Ment Health Serv 2008, 46(8):38-48.
44. Leth-Steenson C, Elbaz ZK, Douglas VI. Mean response times, variability, and skew in the responding of ADHD children: a response time distributional approach. Acta Psychol 104, 167-190.
45. Loo S.K., Barkley R.A. Clinical utility of EEG in attention deficit hyperactivity disorder. Appl Neuropsychol 2005, 12(2):64-76.
46. Loomis A.L., Harvey E.N., Hobart G.A., Harvey E.N., hobart G.A. Cerebral states during sleep as studied by human brain potentials. J Exp Psvchol 1937, 21:127-144.
47. Losier B.M., McGrath P.J., Klein R.M. Error patterns of the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 1996, 37:971-987.
48. Marzano C., Fratello F., Moroni F., Pellicciari M.C., Curcio G., Ferrara M., et al. Slow eye movements and subjective estimates of sleepiness predict EEG power changes during sleep deprivation. Sleep 2007, 30:610-616.
49. Niedermeyer E. Maturation of the EEG: Development of waking and sleep patterns. In: Niedermeyer E, Lopes da Silva F, editors. Electroencephalography - basic principles, clinical applications, and related fields, 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2005. p. 209-235.
50. Olbrich S., Mulert C., Karch S., Trenner M., Leicht G., Pogarell O., et al. EEG-vigilance and bold effect during simultaneous EEG/fMRI measurement. Neuroimage 2009, 45:319-332.
51. Paul R.H., Lawrence J., Williams L.M., Clark R.C., Cooper N., Gordon E. Preliminary validity of IntegNeuro: a new computerized and standardized battery of neurocognitive tests. Int J Neurosci 2005, 115:1549-1567.
52. Plizska S.R. Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action. Neuropsychol Rev 2007, 17:61-72.
53. Rechtschaffen A., Kales A. A manual of standardized terminology technics and scoring systems for sleep of human subjects 1968, US Government Printing Office, Washington, DC.
54. Riccio C.A., Waldrop J.J.M., Reynolds C.R., Lowe P. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 2001, 13(3):326-335.
55. Rostain A.L. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med 2008, 120(3):27-38.
56. Roth B. Clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. Electroencephalogr Clin Neurophysiol 1961, 13:395-399.
57. Satterfield J.H., Cantwell D.P., Saul R.E., Lesser L.I., Podosin R.L. Response to stimulant drug treatment in hyperactive children: prediction from EEG and neurological findings. J Autism Child Schizopr 1973, 3(1):36-48.
58. Soileau EJ Jr. Medications for adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 2008;19(2):254-267 (viii-ix).
59. Soreni N, Crosbie J, Ickowicz A, Schachar R. Stop signal and conners' continuous performance task - test-retest reliability of two inhibition measures In ADHD children. J Atten Disord 2009 [Epub ahead of print].
60. Strijkstra A.M., Beersma D.G., Drayer B., Halbesma N., Daan S. Subjective sleepiness correlates negatively with global alpha (8-12Hz) and positively with central frontal theta (4-8Hz) frequencies in the human resting awake electroencephalogram. Neurosci Lett 2003, 340:17-20.
61. Suffin S.C., Emory W.H. Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clin Electroencephalogr 1995, 26(2):76-83.
62. Swanson J.M. Measures of cognitive functioning appropriate for use in pediatric psychopharmacological research studies. PSychopharmacol Bull 1985, 21:887-895.
63. Swanson J., McBurnett K., Wigal T., Pfiffner L.J., Lerner M.A., Williams L., et al. Effect of Stimulant medication on children with attention deficit disoder: a review of reviews. Exceptional Children 1993, 60:154-162.
64. Teicher M.H., Lowen S.B., Polcari A., Foley M., McGreenery C.E. Novel strategy for the analysis of CPT data provides now insight into the effects of methylphenidate on attentional states in children with ADHD. J Child Adoles Psychopharmacol 2004, 14(2):219-232.
65. Tsuno N., Shigeta M., Hyoki K., Kinoshita T., Ushijima S., Faber P.L., et al. Spatial organization of EEG activity from alertness to sleep stage 2 in old and younger subjects. J Sleep Res 2002, 11:43-51.
66. Ulrich G. Psychiatric electroencephalography. Updated and revised edition (2002) of the original textbook Psychiatrische Elektroenzephalographie. Jena: Gustav Fischer Verlag, 1994; [in German].
67. Young J. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder. Adolesc Med State Art Rev 2008, 19(2):216-228. vii.